CLB — Core Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMid CapNeutral

Annual balance sheet for Core Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	13.8	17.7	15.4	15.1	19.2
Net Total Accounts Receivable
Net Total Receivables	92.9	107	115	123	127
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	166	189	212	223	227
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	182	172	157	153	154
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	569	581	578	586	590
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	89.8	90.8	103	88.1	97.6
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	497	424	394	362	338
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	71.5	156	184	225	252
Total Liabilities & Shareholders' Equity	569	581	578	586	590
Total Common Shares Outstanding